TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today unveiled FutureLink—a new annual gathering of commercial and operational executives from the pharmaceutical and healthcare industries who are dedicated to achieving regulatory compliance and shaping the future of digital drug supply with information sharing networks.
As the only conference of its kind, FutureLink Munich will occur in June 2018, with FutureLink Chicago taking place in November 2018. Both events will provide a forum for a range of business leaders to foster innovative thinking, discuss actionable insights, and develop strategies that address rapidly approaching compliance deadlines—and the analog-to-digital information-sharing transformation taking place in the pharmaceutical and healthcare industries.
Taking place on June 5 – 7, 2018, roughly eight months prior to the February 2019 EU FMD compliance deadline, FutureLink Munich will offer tailored conference experiences for:
Supply chain, compliance, and serialization leaders—who want to participate in focused workshops and develop specific action plans for achieving EU FMD compliance on time; and
Sales, marketing, financial, brand, and other commercial executives—seeking to delve into the most beneficial ways to leverage the use of unique serial number identifiers that accompany each prescription drug that moves through the supply chain for the purposes of extracting long-term business value, achieving new operational efficiencies, and improving the quality of medicines delivered to patients.
“The pharmaceutical and healthcare industries are in the midst of a massive transition. New regulations require complex digital connectivity and data exchange between trading partners, and primitive business processes and architectures are barriers to efficiently manage product recalls, returns, inventory, and more,” said Shabbir Dahod, president and CEO of TraceLink. “By connecting more than 700 pharmaceutical manufacturers, distributors, hospitals and pharmacies to over 260,000 trading partners on our network, we’ve digitized the world’s prescription drug supply chain, providing companies with the best platform for achieving compliance and transformational business value. At FutureLink, industry decision makers will come together to discuss compliance best practices and strategize about how to take advantage of real-time, collaborative information sharing that enables them to operate more cost effectively and deliver better patient outcomes.”
Designed for both commercial and operational executives from the pharmaceutical and healthcare industries, FutureLink will deliver content relating to regulatory compliance and commercial initiatives.
Compliance-specific sessions will center on:
Implementation best practices, customer case studies, creating step-by-step execution plans to ensure compliance, practical user group training on TraceLink software applications, and requirements for rapid partner onboarding.
Commercial and value-oriented tracks will explore:
Brand protection, patient safety and financial reconciliation opportunities related to eliminating drug shortages, initiating instant and accurate product recalls, engaging healthcare providers and patients at the point-of-dispense, and more.
Both groups will have the opportunity to experience visionary keynotes, hands-on knowledge sessions, special interest group discussions, and networking with TraceLink partners, but with content that caters to their specific interests.
Registration for FutureLink Munich is now open. For more information and to reserve a seat, please visit FutureLink Munich.
TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including three consecutive years on Deloitte’s Technology Fast 500 (ranked number 177 in 2017), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost.
Macallan Whisky picks Izon® Technology as part of a comprehensive anti-counterfeit solution
(De La Rue Authentication Solutions)
The Edrington Group, makers of world renowned The Macallan Highland Single Malt Scotch Whisky, faced a challenge when re-filled used
bottles, intact with labels, began appearing on shelves under their brand name. This posed a serious consumer safety, as well as a global
brand issue. For a solution, they turned to Authentication Solutions for the key overt component of a comprehensive solution.
Epson builds market awareness of authentic product through implementation of layered AC tech
(De La Rue Authentication Solutions)
Epson Latin America estimated that 20% of the product in the market was counterfeit and entering the supply chain through local distributors. The existing anti-counterfeiting ink technology was compromised. Epson developed a new strategy to target unauthorized distributors in key countries and build market awareness of authentic product.
The StellaGuard™ solution leverages the benefits of a barcode and connects it with a three-dimensional visual reference that provides instantaneous authentication with copy-detect protection. StellaGuard™ is a patented and elegant solution to protect your assets, enabling trusted stakeholders, including customers, to authenticate a product using common everyday smart devices.
The smartphone: a new tool to spot fake products
The development of new smartphone technologies offers brands the opportunity to fight counterfeiting more efficiently and drive competitive differentiation by turning their products into smart assets. This paper examines the process of placing the consumer as one of the key actors against illicit trade and creating new business intelligence capabilities for brands.
Pharma Security World 2018: "Anti-counterfeiting and Brand Safety"
March 20-21, 2018 - London, UK
Global Illicit Trade Summit 2018: Out of the shadows
March 22, 2018 - Kuala Lumpur
4XScience 2018 E2E Supply Chain Serialization Benchmark Workshop
March 27-28, 2018 - Brussels, Belgium
Robert Schuman Foundation conference: Smuggling, counterfeiting and the financing of terrorism – mobilising economic stakeholders
April 11, 2018 - Brussels, Belgium
April 17-19, 2018 - New York (NY), USA
4th Global Brand Protection EU Innovation Programme (GBPIP)
April 26-27, 2018 - London, UK
IACC 2018 Annual Spring Conference
May 16-18, 2018 - Seattle (WA), USA
May 29 - June 01, 2018 - Milan, Italy
Partnership for Safe Medicines 2018 Interchange
June 07, 2018 - Washington D.C., USA
June 25-27, 2018 - London, UK
September 2018 (dates tbc) - Switzerland
Rx-360 Global Life Science Supply Chain 2018 Conference: Driving Innovative Quality Strategies
September 25-26, 2018 - Miami (FL), USA
2018 A-CAPP Center Brand Protection Strategy Summit
October 02-03, 2018 - East Lansing (MI), USA
13th Security Document Summit (SDS)
October 17-18, 2018 - Beijing, China
Anti-Counterfeit & Currency Expo (ACCE)
November 06-08, 2018 - Las Vegas (NV), USA